REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of shares

6 May 2021 09:12

RNS Number : 7699X
Danakali Limited
06 May 2021
 

Announcement

Thursday, 6 May 2021

 

Issue of shares

 

Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) confirms that it has issued a total of 47,565,999 new fully paid shares (Shares) pursuant to the placement announced by the Company on 29 April 2021.

 

A completed Appendix 2A has been lodged together with this announcement in respect of the Placement Shares (47,296,231 shares) and Other PDMR/PCA Shares (269,768 shares) issued and is available for download at: https://www2.asx.com.au/markets/trade-our-cash-market/announcements.dnk.

 

Secondary Trading Exemption - s708A Notice

 

Danakali gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act) of the following:

· The Shares were issued without disclosure under Part 6D 2 of the Act;

· This notice is being given under section 708A(5)(e) of the Act;

· As at the date of this notice, the Company has complied with:

The provisions of Chapter 2M of the Act as they apply to the Company; and

Section 674 of the Act; and

· As at the date of this notice, there is no information:

That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

o The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

o The rights and liabilities attaching to the Shares.

 

Disclosure information - Other PDMR/PCA Shares

 

The issue of 269,768 Other PDMR/PCA Shares is not subject to shareholder approval and will fall within the Company's 15% placement capacity under ASX LR 7.1.

 

The Other PDMR/PCA Shares rank pari passu with the existing ordinary shares in the Company. Application will be made for the Other PDRM/PCA Shares to be admitted to the Official List of the FCA (Standard Segment) and to trading on the London Stock Exchange's Main Market (LSE Admission). LSE Admission is expected to occur on Thursday, 6 May 2021.

 

Total voting rights

 

Conditional on admission of the Other PDMR/PCA Shares, the Company will have 367,254,346 ordinary shares on issue, all of which have the right to one vote. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company will be 367,254,346 which figure may be used by shareholders or other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company.

 

 

 

For more information, please contact:

 

Danakali

Seamus Cornelius

Executive Chairman

+61 8 6266 8368

Mark Riseley

Head of Corporate Development

+61 8 6266 8368

 

Visit the Company's website: www.danakali.com 

Follow Danakali on LinkedIn: www.linkedin.com/company/danakali-limited

Subscribe to Danakali on YouTube: www.youtube.com/channel/UChGKN4-M4lOvPKxs9b-IJvw

 

Announcement authorised for release by the Company Secretary of Danakali.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKABKFBKKCPK
Date   Source Headline
4th Jan 20217:00 amRNSTotal Voting Rights
9th Dec 20207:00 amRNSChange of Registered Office
4th Dec 20207:00 amRNSChairman's Letter
1st Dec 20209:00 amRNSTotal Voting Rights and Capital
2nd Nov 20209:00 amRNSTotal Voting Rights and Capital
30th Oct 20207:05 amRNSAppendix 5B
30th Oct 20207:00 amRNSQuarterly Report
26th Oct 20207:00 amRNSAFC investment update
13th Oct 20207:00 amRNSDanakali appoints industry expert as COO
13th Oct 20207:00 amRNSProposed issue of unlisted options
8th Oct 20207:02 amRNSAppointment of Preferred Power Contractor
1st Oct 20209:00 amRNSTotal Voting Rights and Capital
30th Sep 20207:00 amRNSCompany Presentation
14th Sep 20207:00 amRNSDanakali at Africa Fertilizer Agribusiness 2020
3rd Sep 20207:02 amRNSDanakali Investor Webinar
2nd Sep 20207:00 amRNSColluli Project Update - EPCM Phase 2 Complete
1st Sep 20209:00 amRNSIssue of unlisted options; PDMR & PCA transactions
1st Sep 20209:00 amRNSAppendix 3Y
1st Sep 20209:00 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSHalf-year Report
21st Aug 20208:42 amRNSProposed issue of unlisted options
20th Aug 20207:00 amRNSAppointment of Accommodation & Support Contactor
3rd Aug 20209:14 amRNSTotal voting rights and capital
3rd Aug 20209:00 amRNSAppendix 3Y - Change of Director’s Interest Notice
3rd Aug 20209:00 amRNSAppendix 3Z - Final Director’s Interest Notice
3rd Aug 20209:00 amRNSAppendix 3X - Initial Director’s Interest Notice
3rd Aug 20209:00 amRNSAppendix 3Z - Final Director’s Interest Notice
3rd Aug 20207:00 amRNSChanges to Board of Directors
28th Jul 20207:00 amRNSSustainability Investor Webinar
24th Jul 20207:00 amRNSAppointment of UK Broker
24th Jul 20207:00 amRNSJune 2020 Quarterly Report
22nd Jul 20207:00 amRNSColluli Mine Development Approval
21st Jul 20209:00 amRNSAmended Constitution
16th Jul 20207:00 amRNSResults of AGM
9th Jul 202012:29 pmRNSAGM – important information
9th Jul 20209:49 amRNSIssue of unlisted options
8th Jul 20209:07 amRNSProposed issue of unlisted options
1st Jul 20209:00 amRNSTotal Voting Rights and Capital
22nd Jun 20207:00 amRNSAdvancement of Colluli SOP Project
16th Jun 20207:00 amRNSColluli Sustainability Report
12th Jun 20207:05 amRNSLetter to Shareholders
12th Jun 20207:00 amRNSNotice of AGM
12th Jun 20207:00 amRNSNotification of PCA transactions
12th Jun 20207:00 amRNSAppendix 3Y
11th Jun 20207:00 amRNSInvestor presentation
10th Jun 20207:00 amRNSDanakali Investor Webinar
5th Jun 20209:00 amRNSNotification of PDMR and PCA transactions
5th Jun 20209:00 amRNSAppendix 3Y
1st Jun 20209:00 amRNSTotal Voting Rights and Capital
1st Jun 20207:00 amRNSAFC investment update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.